Table 2.
Effects of increasing dietary fibre intakes on cardiometabolic risk factors in patients with established CVD
Outcome | Trials | Participants (I/C) | Initial I2 | MD (95% CI) | Grade |
---|---|---|---|---|---|
Total cholesterol (mmol/L) | 3 | 117/110 | 99% | − 0.42 (− 0.78 to − 0.05) | Low |
LDL cholesterol (mmol/L) | 3 | 117/110 | 99% | − 0.47 (− 0.85 to − 0.10) | Low |
HDL cholesterol (mmol/L) | 3 | 117/110 | 99% | 0.08 (− 0.02 to 0.17) | Low |
Triglycerides (mmol/L) | 3 | 117/110 | 91% | − 0.03 (− 0.15 to 0.08) | Low |
Systolic blood pressure (mmHg) | 1 | 38/38 | - | − 1.2 (− 2.0 to − 0.4) | Very low |
Diastolic blood pressure (mmHg) | 1 | 38/38 | - | − 3.6 (− 4.0 to − 3.2) | Very low |
Body weight (kg) | 1 | 61/53 | - | − 0.20 (− 0.37 to − 0.04) | Very low |
BMI (kg/m2) | 2 | 99/91 | 98% | − 0.30 (− 0.69 to 0.09) | Low |
Waist circumference (cm) | 1 | 61/53 | - | − 0.5 (− 0.6 to − 0.4) | Very low |
Fasting plasma glucose (mmol/L) | 2 | 99/91 | 100% | − 1.23 (− 2.13 to − 0.33) | Low |
Fasting plasma insulin (pmol/L) | 1 | 38/38 | - | − 10.8 (− 13.2 to − 8.4) | Very low |